Aptamer sales pipeline 'strong', more than £3m in advanced discussions
13th May 2024 10:47
(Sharecast News) - Life sciences business Aptamer said on Monday that its current sales pipeline was "strong", with over £3.0m in advanced stage discussions.
Read moreAptamer applies for patent over binder sequences developed with Unilever
8th Apr 2024 11:25
(Sharecast News) - Aptamer Group announced the submission of a patent application safeguarding newly-crafted Optimer binder sequences on Monday.
Read moreAptamer reports decent technical, commercial progress
15th Dec 2023 11:06
(Sharecast News) - Aptamer Group reported solid progress on both the technical and commercial fronts on Friday as it held its annual general meeting.
Read moreAptamer inks £0.55m agreement with biotech firm
14th Dec 2023 16:43
(Sharecast News) - Aptamer Group announced a significant agreement with a biotechnology company on Thursday, focussed on genetic medicines.
Read moreAptamer secures two contracts with big pharma firm
17th Aug 2023 15:51
(Sharecast News) - Life sciences company Aptamer Group has secured two new contracts with one of the world's top five pharmaceutical companies, it announced on Thursday, with an estimated worth of up to £0.22m.
Read moreAptamer announces four significant new contracts
7th Jul 2023 13:40
(Sharecast News) - Life sciences company Aptamer Group announced a significant update on recent contract wins on Friday, totalling up to £0.51m over the next six months.
Read moreAptamer warns on profits amid slow pipeline conversion
5th May 2023 15:48
(Sharecast News) - Life sciences company Aptamer Group said in a trading update on Friday that revenue in the 10 months ended 30 April totalled around £1.4m.
Read moreAptamer warns on FY revenues
3rd Jan 2023 08:36
(Sharecast News) - Biotech company Aptamer Group warned on Tuesday that while full-year revenues may fall short of market expectations, they were still likely to come in "materially ahead" of the level achieved in the previous financial year.
Read more